MHE Question of the Week: Your Opinion of the Change Healthcare Cyberattack

News
Article

Share your view about the Change Healthcare cyberattack.

Change Healthcare, a revenue cycle and healthcare analytics company now part of UnitedHealth Group’s Optum division, was cyberattacked on Feb. 21, according to a Securities and Exchange Commission (SEC) filing by UnitedHealth. To contain the attack, Change Healthcare’s information systems were disconnected. UnitedHealth said in the SEC filing that a “suspected nation-state associated cyber security threat actor” had been identified but hasn’t released any information on the perpetrator since. The outage has affected pharmacies throughout the country, including those at some military medical facilities. The American Hospital Association recommended that all healthcare organizations disrupted or “potentially exposed by this incident” consider disconnection from Optum. Numerous status updates on the situation on an Optum website, including one this morning at 8:04 a.m. EST, have said, "we have a high level of confidence that Optum, UnitedHealthcare and UnitedHealth Group systems have not been affected by this issue.”

Please pick the statement that most closely resembles your opinion of the Change Healthcare cyberattack

It is a dangerous sign of the vulnerability of healthcare information systems.
The damage was limited, and it shows the strength of the defenses against cyberattacks.
UnitedHealth Group needs to do a better job of defending itself against cyberattacks.
Healthcare companies need to move faster to strengthen their cybersecurity defenses to keep such outages from happening in the future.
Cyberattacks are common and need to be dealt with, but we shouldn’t get panicky about them.
Recent Videos
Jill Zouzoulas, MD, FACR, an expert on biologic therapies
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Related Content
© 2024 MJH Life Sciences

All rights reserved.